← All stocks

Praxis Precision Medicines, Inc.

PRAX Net selling
CIK 0001689548 #930 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$44.27M
$0.00 on a plan · $11.08M straight out of an exercise
Sold at will
$33.20M
10 of 28 sales
Net
−$44.27M
−$33.20M against sales at will

By person

14 insiders · 31 transactions
27.0×

Marcio Souza holds 27.0 times base salary in stock. $17.84M of shares against $659.20K in salary for 2025.

Salary from the company's own proxy. The shares are what Marcio Souza last reported holding, valued at $315.71, the price Common Stock was last bought or sold at on the open market here, on 24 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Adage Capital Management, L.P. entity
10% owner
$33.20M (10)
−$33.20M
2,060,175
7.38%
$650.41M
+18.0%
Nemiroff Alex
General Counsel and Secretary
$4.85M (4) scheduled
−$4.85M
26,011
0.0932%
$8.21M
+137.4%
DeSimone Jill
Director
$3.61M (12) scheduled
−$3.61M
2,337
0.0084%
$737.80K
+141.9%
Mastrocola Lauren
Principal Accounting Officer
$2.61M (2) scheduled
−$2.61M
13,573
0.0486%
$4.28M
+111.2%
Souza Marcio
Chief Executive Officer
56,495
0.2023%
$17.84M
+184.0%
Kelly Timothy Edwin
Chief Financial Officer
31,167
0.1116%
$9.84M
+156.7%
Sniecinski Megan
Chief Operating Officer
28,664
0.1027%
$9.05M
+37.0%
MITCHELL DEAN J
Director
18,622
0.0667%
$5.88M
+272.4%
YOUNG WILLIAM D
Director
3,269
0.0117%
$1.03M
+72.2%
Arbuckle Stuart A
Director
2,537
0.0091%
$800.94K
KINDLER JEFFREY B
Director
2,537
0.0091%
$800.94K
Norden Gregory
Director
1,559
0.0056%
$492.18K
+729.3%
Chodakewitz Jeffrey
Director
1,371
0.0049%
$432.83K
Cudkowicz Merit Ester
Director
1,371
0.0049%
$432.83K
Insider
Date
Role
Action
Shares
Price
Amount
DeSimone Jill
24 Jun 2026
Director
Sold after exercise
837
$315.71
$264.25K
DeSimone Jill
24 Jun 2026
Director
Sold after exercise
1,279
$314.90
$402.76K
DeSimone Jill
24 Jun 2026
Director
Sold after exercise
504
$313.66
$158.09K
DeSimone Jill
24 Jun 2026
Director
Sold after exercise
1,004
$312.83
$314.08K
DeSimone Jill
24 Jun 2026
Director
Sold after exercise
2,854
$311.91
$890.20K
DeSimone Jill
24 Jun 2026
Director
Sold after exercise
1,750
$310.89
$544.06K
DeSimone Jill
24 Jun 2026
Director
Sold after exercise
999
$309.38
$309.07K
DeSimone Jill
24 Jun 2026
Director
Sold after exercise
1,240
$308.24
$382.22K
DeSimone Jill
24 Jun 2026
Director
Sold after exercise
683
$306.77
$209.52K
DeSimone Jill
24 Jun 2026
Director
Sold after exercise
320
$305.31
$97.70K
DeSimone Jill
24 Jun 2026
Director
Sold after exercise
120
$303.13
$36.38K
DeSimone Jill
24 Jun 2026
Director
Sold after exercise
10
$301.44
$3.01K
Mastrocola Lauren
20 Nov 2025
Principal Accounting Officer
Sold after exercise
2,145
$192.71
$413.37K
Mastrocola Lauren
20 Nov 2025
Principal Accounting Officer
Sold after exercise
11,455
$191.96
$2.20M
Nemiroff Alex
20 Nov 2025
General Counsel and Secretary
Sold after exercise
9,100
$194.30
$1.77M
Nemiroff Alex
20 Nov 2025
General Counsel and Secretary
Sold after exercise
977
$193.23
$188.79K
Nemiroff Alex
20 Nov 2025
General Counsel and Secretary
Sold after exercise
13,339
$192.53
$2.57M
Nemiroff Alex
20 Nov 2025
General Counsel and Secretary
Sold after exercise
1,714
$190.86
$327.14K

What was left out

Form 4 filings counted 36
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 18
Sales at will 10
Transactions with no price 0
Shares from compensation/vesting 168,583
History held since 20 Oct 2020